Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2019-11-01 21:17:25
Reporting Period:
Accepted Time:
2019-11-01 21:17:25
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1722964 Y-Mabs Therapeutics Inc. YMAB () 4
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1245624 James Healy C/o Sofinnova Investments, Inc.,
3000 Sand Hill Road, Bldg. 4, Suite 250
Menlo Park CA 94025
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-10-30 90,000 $28.00 2,194,278 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
  1. Such shares of the Company's Common Stock are owned by Sofinnova Venture Partners X, L.P. ("Sofinnova X"). The Reporting Person is a managing member of Sofinnova Management X, L.L.C., the General Partner of Sofinnova X, and as such has shared voting and dispositive power over such shares with Dr. Anand Mehra and Michael F. Powell, Ph.D., the other managing members of Sofinnova Management X, L.L.C. The Reporting Person disclaims beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein.